Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility
BRAF/MEK抑制剂治疗转移性黑色素瘤患者的心脏毒性:真实世界发生率、危险因素和可逆性分析
期刊:Acta Oncologica
影响因子:2.2
doi:10.2340/1651-226X.2025.42567
Oddershede, Jonas K; Meklenborg, Ida K; Bastholt, Lars; Guldbrandt, Louise M; Schmidt, Henrik; Friis, Rasmus B